Edward Minor
Child & Adolescent Psychiatry · Columbus, GANPI 1447341979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $906 and has fallen 91.0% since, to $81 in 2025.
Across 187 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$786
- AbbVie$624
- Otsuka America Pharmaceutical, Inc.$469
- Neurocrine Biosciences, Inc.$342
- Teva Pharmaceuticals USA, Inc.$299
- Alkermes, Inc.$283
- plus $578 from 10 others
What the payments were for
- Food & beverage$3,381100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 42 | $786 |
| AbbVie(2 entities) | 41 | $624 |
| Otsuka America Pharmaceutical, Inc. | 23 | $469 |
| Neurocrine Biosciences, Inc. | 17 | $342 |
| Teva Pharmaceuticals USA, Inc. | 18 | $299 |
| Alkermes, Inc. | 16 | $283 |
| Lundbeck LLC | 11 | $207 |
| Indivior Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Eisai Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $13 |
| Neuronetics, Inc. | 1 | $11 |
How this compares
$3,381 in reported general payments places this provider in the 85th percentile of 91 child & adolescent psychiatry providers in Georgia.
See all child & adolescent psychiatry providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate ErMethylphenidate Hcl | 20 | $6,715 |
| Divalproex Sodium | 45 | $1,747 |
| Aripiprazole | 39 | $1,434 |
| Quetiapine Fumarate | 89 | $1,346 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 41 | $1,167 |
| Ziprasidone Hcl | 14 | $1,159 |
| Olanzapine | 41 | $1,071 |
| Trazodone Hcl | 57 | $496 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $491 |
| Haloperidol | 18 | $463 |
| Risperidone | 37 | $455 |
| Buspirone Hcl | 40 | $429 |
| Bupropion XlBupropion Hcl | 21 | $396 |
| Prazosin Hcl | 14 | $301 |
| Duloxetine Hcl | 20 | $287 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Columbus
- Britney FarmerColumbus$2K
- Suneel KatragaddaAtlanta$460K
- Kevin WindersSavannah$225K
- Annamarie PaulsenConyers$25K
- Haolat BabalakinBerkeley Lake$16K
- Heerain ShahSuwanee$14K
- Olujimi AdefisanAtlanta$14K
- Deepti BhasinWarner Robins$11K
- Mhd AlkhatibAtlanta$7K
- Mary HuberAtlanta$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.